Showing results (141-150 of 4,635) with videos related to
Sort By:
Pageof 464
Anti-Cancer Drugs|September 14, 2021
A review of research progress on mechanisms and overcoming strategies of acquired osimertinib resistanceFanjie Qu, Yi Zhou, Weiwei YuAnti-Cancer Drugs|September 6, 2021
MicroRNA-148a/152 cluster restrains tumor stem cell phenotype of colon cancer via modulating CCT6AXin Peng, Guanming Chen, Baozhou Lv, et al.Anti-Cancer Drugs|September 6, 2021
The relevance of macrocytosis induction during neoadjuvant dose-dense chemotherapy in breast cancer patientsTihana Boraska Jelavić, Mario Podrug, Marija Ban, et al.Anti-Cancer Drugs|July 15, 2016
An in-vitro evaluation of three types of drug-eluting microspheres loaded with irinotecanPhilippe L Pereira, Stephen Plotkin, Renee Yu, et al.Anti-Cancer Drugs|May 27, 2015
MDI 301 suppresses myeloid leukemia cell growth in vitro and in vivo without the toxicity associated with all-trans retinoic acid therapyMuhammad N Aslam, Shannon McClintock, Shazli P Khan, et al.Anti-Cancer Drugs|May 7, 2015
All-trans retinoic acid suppresses topoisomerase IIα through the proteasomal pathwayXiaoting Li, Yuan Li, Xin Shen, et al.Anti-Cancer Drugs|December 24, 1997
Antitumor activity of oxaliplatin in combination with 5-fluorouracil and the thymidylate synthase inhibitor AG337 in human colon, breast and ovarian cancersE Raymond, C Buquet-Fagot, S Djelloul, et al.Anti-Cancer Drugs|December 24, 1997
Prevention of peritoneal metastasis of cancer with dextran sulfate--an experimental study in miceA Hagiwara, K Sawai, C Sakakura, et al.Anti-Cancer Drugs|August 1, 1997
Overview of the tolerability of 'Tomudex' (raltitrexed): collective clinical experience in advanced colorectal cancerJ ZalcbergAnti-Cancer Drugs|April 14, 2020
In-vitro and in-vivo investigations into the carbene-gold anticancer drug candidates NHC*-Au-SCSNMe2 and NHC*-Au-S-GLUC against advanced prostate cancer PC3Wolfgang Walther, Dhiyaa Althagafi, Danielle Curran, et al.Pageof 464